Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             264 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial Richmond, P.C.
 2012
 30 Supplement 2 p. 6163-6174
12 p.
 artikel
2 A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi Lu, Ying-Jie
 2012
 30 Supplement 2 p. 3405-3412
8 p.
 artikel
3 Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: Implications for targeted vaccination programs Rank, Claudia
 2012
 30 Supplement 2 p. 5755-5760
6 p.
 artikel
4 A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination—Possible stimulated reporting? McNeil, Michael M.
 2012
 30 Supplement 2 p. 2421-2426
6 p.
 artikel
5 Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner Taguchi, Ayumi
 2012
 30 Supplement 2 p. 5368-5372
5 p.
 artikel
6 A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children Anh, Dang Duc
 2012
 30 Supplement 2 p. A114-A121
nvt p.
 artikel
7 Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses Honda-Okubo, Yoshikazu
 2012
 30 Supplement 2 p. 5373-5381
9 p.
 artikel
8 Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak Abedi, Glen R.
 2012
 30 Supplement 2 p. 7052-7058
7 p.
 artikel
9 Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010 Ouandaogo, Claude-Roger
 2012
 30 Supplement 2 p. B46-B51
nvt p.
 artikel
10 A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children Aquino, Amalia Guadalupe Becerra
 2012
 30 Supplement 2 p. 6492-6500
9 p.
 artikel
11 A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice Geluk, Annemieke
 2012
 30 Supplement 2 p. 7513-7521
9 p.
 artikel
12 A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory Loew-Baselli, Alexandra
 2012
 30 Supplement 2 p. 5956-5966
11 p.
 artikel
13 An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP–IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children Klein, Nicola P.
 2012
 30 Supplement 2 p. 668-674
7 p.
 artikel
14 Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA) Shibl, Atef M.
 2012
 30 Supplement 2 p. G32-G36
nvt p.
 artikel
15 Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition Trible, Benjamin R.
 2012
 30 Supplement 2 p. 4079-4085
7 p.
 artikel
16 Antibody response to allelic variants of 19kDa fragment of MSP-1: Recognition of a variant and protection associated with ethnicity in Assam, India Lourembam, Sonia D.
 2012
 30 Supplement 2 p. 767-773
7 p.
 artikel
17 An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women Jacobsen, Steven J.
 2012
 30 Supplement 2 p. 4585-4587
3 p.
 artikel
18 A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil Weckx, Lily Yin
 2012
 30 Supplement 2 p. 7566-7572
7 p.
 artikel
19 A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings Miyasaka, Tomomitsu
 2012
 30 Supplement 2 p. 3304-3310
7 p.
 artikel
20 A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18–49 years of age Baxter, Roger
 2012
 30 Supplement 2 p. 3053-3060
8 p.
 artikel
21 Ascaris suum enolase is a potential vaccine candidate against ascariasis Chen, Ning
 2012
 30 Supplement 2 p. 3478-3482
5 p.
 artikel
22 A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles Raghuwanshi, Dharmendra
 2012
 30 Supplement 2 p. 7292-7299
8 p.
 artikel
23 Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs Sanford, Brenton J.
 2012
 30 Supplement 2 p. 6249-6255
7 p.
 artikel
24 Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life Wang, Yangyang
 2012
 30 Supplement 2 p. 5708-5713
6 p.
 artikel
25 A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli Zeng, Weiguang
 2012
 30 Supplement 2 p. 4800-4806
7 p.
 artikel
26 A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge Reynolds, Matthew R.
 2012
 30 Supplement 2 p. 4465-4475
11 p.
 artikel
27 A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season Tennis, Patricia
 2012
 30 Supplement 2 p. 6099-6102
4 p.
 artikel
28 A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China Lu, Li
 2012
 30 Supplement 2 p. 5094-5098
5 p.
 artikel
29 A Vaxfectin®-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes Veselenak, Ronald L.
 2012
 30 Supplement 2 p. 7046-7051
6 p.
 artikel
30 Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1) Nayak, Baibaswata
 2012
 30 Supplement 2 p. 2220-2227
8 p.
 artikel
31 A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models De Bernardis, Flavia
 2012
 30 Supplement 2 p. 4490-4498
9 p.
 artikel
32 BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: Association of protection with post-vaccination and post-challenge immune responses Twine, Susan
 2012
 30 Supplement 2 p. 3634-3645
12 p.
 artikel
33 Barriers to HPV immunization for African American adolescent females Hamlish, Tamara
 2012
 30 Supplement 2 p. 6472-6476
5 p.
 artikel
34 Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice Jiang, Wenzheng
 2012
 30 Supplement 2 p. 758-766
9 p.
 artikel
35 Bovine tuberculosis vaccine research: Historical perspectives and recent advances Waters, W. Ray
 2012
 30 Supplement 2 p. 2611-2622
12 p.
 artikel
36 Cationic liposome–DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice Dong, Libo
 2012
 30 Supplement 2 p. 254-264
11 p.
 artikel
37 Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming van der Velden, Maikel V.W.
 2012
 30 Supplement 2 p. 6127-6135
9 p.
 artikel
38 Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice Dendouga, Najoua
 2012
 30 Supplement 2 p. 3126-3135
10 p.
 artikel
39 Challenges in confirming a varicella outbreak in the two-dose vaccine era Mahamud, Abdirahman
 2012
 30 Supplement 2 p. 6935-6939
5 p.
 artikel
40 Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco) Elmdaghri, Naima
 2012
 30 Supplement 2 p. G46-G50
nvt p.
 artikel
41 Characterisation of antibody responses in pigs induced by recombinant oncosphere antigens from Taenia solium Jayashi, César M.
 2012
 30 Supplement 2 p. 7475-7480
6 p.
 artikel
42 Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study Opel, Douglas J.
 2012
 30 Supplement 2 p. 1269-1275
7 p.
 artikel
43 CIGB-247: A VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors Bequet-Romero, Mónica
 2012
 30 Supplement 2 p. 1790-1799
10 p.
 artikel
44 Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats Pravetoni, M.
 2012
 30 Supplement 2 p. 4617-4624
8 p.
 artikel
45 Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study Chatterjee, Archana
 2012
 30 Supplement 2 p. 3360-3368
9 p.
 artikel
46 Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: Waning pertussis immunity in a highly immunized population and the need for adolescent booster doses Lai, F.Y.
 2012
 30 Supplement 2 p. 3566-3571
6 p.
 artikel
47 Comparison of multiple estimates of efficacy for influenza vaccine Loeb, Mark
 2011
 30 Supplement 2 p. 1-4
4 p.
 artikel
48 Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients Lu, Ching-Lan
 2012
 30 Supplement 2 p. 3526-3533
8 p.
 artikel
49 Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice Han, Ji Eun
 2012
 30 Supplement 2 p. 4127-4134
8 p.
 artikel
50 Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia Lewis, Kristen D.C.
 2012
 30 Supplement 2 p. A159-A166
nvt p.
 artikel
51 Conducting vaccine clinical trials in sub-Saharan Africa: Operational challenges and lessons learned from the Meningitis Vaccine Project Marchetti, Elisa
 2012
 30 Supplement 2 p. 6859-6863
5 p.
 artikel
52 Consistency of HLA associations between two independent measles vaccine cohorts: A replication study Ovsyannikova, Inna G.
 2012
 30 Supplement 2 p. 2146-2152
7 p.
 artikel
53 Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2 Lin, Hui-xing
 2012
 30 Supplement 2 p. 6307-6313
7 p.
 artikel
54 Contents 2012
 30 Supplement 2 p. vi-
1 p.
 artikel
55 Cost-effectiveness of hepatitis A vaccination for adults in Belgium Luyten, Jeroen
 2012
 30 Supplement 2 p. 6070-6080
11 p.
 artikel
56 Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands Meijboom, M.J.
 2012
 30 Supplement 2 p. 4691-4700
10 p.
 artikel
57 Cost of production of live attenuated dengue vaccines: A case study of the Instituto Butantan, Sao Paulo, Brazil Mahoney, R.T.
 2012
 30 Supplement 2 p. 4892-4896
5 p.
 artikel
58 Current epidemiology of rubella and congenital rubella syndrome in Australia: Progress towards elimination Song, Ning
 2012
 30 Supplement 2 p. 4073-4078
6 p.
 artikel
59 Current issues with the immunization program in Japan: Can we fill the “vaccine gap”? Saitoh, Akihiko
 2012
 30 Supplement 2 p. 4752-4756
5 p.
 artikel
60 Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8+T cell mediated immunity against Trypanosoma cruzi Gupta, Shivali
 2012
 30 Supplement 2 p. 7179-7186
8 p.
 artikel
61 Descendant of daughter Brazilian BCG Moreau substrain in Poland Krysztopa-Grzybowska, Katarzyna
 2012
 30 Supplement 2 p. 5512-5518
7 p.
 artikel
62 Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain Altman, Eleonora
 2012
 30 Supplement 2 p. 7332-7341
10 p.
 artikel
63 Development of a scaled-down aerobic fermentation model for scale-up in recombinant protein vaccine manufacturing Farrell, Patrick
 2012
 30 Supplement 2 p. 5695-5698
4 p.
 artikel
64 Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer Sims, Robert B.
 2012
 30 Supplement 2 p. 4394-4397
4 p.
 artikel
65 Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness Rheingans, Richard
 2012
 30 Supplement 2 p. A15-A23
nvt p.
 artikel
66 Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine Bodemer, Nicolai
 2012
 30 Supplement 2 p. 3747-3756
10 p.
 artikel
67 Early infection dynamics after experimental challenge with Mycobacterium avium subspecies paratuberculosis in calves reveal limited calf-to-calf transmission and no impact of Hsp70 vaccination Santema, Wiebren J.
 2012
 30 Supplement 2 p. 7032-7039
8 p.
 artikel
68 Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand Muangchana, Charung
 2012
 30 Supplement 2 p. 2839-2847
9 p.
 artikel
69 Editorial Board 2012
 30 Supplement 2 p. CO2-
1 p.
 artikel
70 Editorial Board 2012
 30 Supplement 2 p. CO2-
1 p.
 artikel
71 Editorial Board/Aims and Scope 2012
 30 Supplement 2 p. CO2-
1 p.
 artikel
72 Editorial Board/Aims and Scope 2012
 30 Supplement 2 p. CO2-
1 p.
 artikel
73 Editorial Board/Aims and Scope 2012
 30 Supplement 2 p. CO2-
1 p.
 artikel
74 Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience Djingarey, Mamoudou H.
 2012
 30 Supplement 2 p. B40-B45
nvt p.
 artikel
75 Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation Fisman, David N.
 2012
 30 Supplement 2 p. 7601-7607
7 p.
 artikel
76 Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients Forstner, C.
 2012
 30 Supplement 2 p. 5449-5452
4 p.
 artikel
77 Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza Örtqvist, Åke
 2012
 30 Supplement 2 p. 5699-5702
4 p.
 artikel
78 Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: A cluster randomized trial in Karachi, Pakistan Khan, M. Imran
 2012
 30 Supplement 2 p. 5389-5395
7 p.
 artikel
79 Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users Tran, Thanh Q.
 2012
 30 Supplement 2 p. 342-349
8 p.
 artikel
80 Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial Le Corre, Nicole
 2012
 30 Supplement 2 p. 7522-7528
7 p.
 artikel
81 Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers van der Sluijs, M.T.W.
 2012
 30 Supplement 2 p. 647-655
9 p.
 artikel
82 Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults Pathan, Ansar A.
 2012
 30 Supplement 2 p. 5616-5624
9 p.
 artikel
83 Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis development Peters, Jennifer L.
 2012
 30 Supplement 2 p. 6706-6712
7 p.
 artikel
84 Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial Madhi, S.A.
 2012
 30 Supplement 2 p. A44-A51
nvt p.
 artikel
85 Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.) Abd Alla, Mohamed D.
 2012
 30 Supplement 2 p. 3068-3075
8 p.
 artikel
86 Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs De Vleeschauwer, Annebel R.
 2012
 30 Supplement 2 p. 5557-5563
7 p.
 artikel
87 Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions Seo, Hwi Won
 2012
 30 Supplement 2 p. 6671-6677
7 p.
 artikel
88 Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial Cunliffe, Nigel A.
 2012
 30 Supplement 2 p. A36-A43
nvt p.
 artikel
89 Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya Feikin, Daniel R.
 2012
 30 Supplement 2 p. A52-A60
nvt p.
 artikel
90 Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer Zhu, Daming
 2012
 30 Supplement 2 p. 189-194
6 p.
 artikel
91 Eliciting broad neutralizing antibody to HIV-1: Envelopes of different lentivirus cross immunization by prime-boost vaccination Luo, Zhenwu
 2012
 30 Supplement 2 p. 5316-5323
8 p.
 artikel
92 Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin Liu, Xiaoyu
 2012
 30 Supplement 2 p. 6527-6533
7 p.
 artikel
93 Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2 Tian, Da-Yong
 2012
 30 Supplement 2 p. 3587-3594
8 p.
 artikel
94 Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon Hanna-Wakim, Rima
 2012
 30 Supplement 2 p. G11-G17
nvt p.
 artikel
95 Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice? Bilcke, Joke
 2012
 30 Supplement 2 p. 2795-2800
6 p.
 artikel
96 Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales Pitman, R.J.
 2012
 30 Supplement 2 p. 1208-1224
17 p.
 artikel
97 Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: A multimodal pilot project Nowalk, Mary Patricia
 2012
 30 Supplement 2 p. 5978-5982
5 p.
 artikel
98 Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors Fang, Xinkui
 2012
 30 Supplement 2 p. 1313-1321
9 p.
 artikel
99 Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice Lumsden, Joanne M.
 2012
 30 Supplement 2 p. 3311-3319
9 p.
 artikel
100 Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis Bettinger, Julie A.
 2012
 30 Supplement 2 p. 4023-4027
5 p.
 artikel
101 Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus Kumar, Manish
 2012
 30 Supplement 2 p. 6142-6149
8 p.
 artikel
102 Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates Boonnak, Kobporn
 2012
 30 Supplement 2 p. 5603-5610
8 p.
 artikel
103 Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer Arbyn, Marc
 2012
 30 Supplement 2 p. F88-F99
nvt p.
 artikel
104 Factors influencing pandemic influenza vaccination of healthcare workers—A systematic review Prematunge, Chatura
 2012
 30 Supplement 2 p. 4733-4743
11 p.
 artikel
105 Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south Frew, Paula M.
 2012
 30 Supplement 2 p. 4200-4208
9 p.
 artikel
106 Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: Results from a national survey Blondel, Béatrice
 2012
 30 Supplement 2 p. 5661-5665
5 p.
 artikel
107 Feasibility of a randomized controlled trial to evaluate Text Reminders for Immunization Compliance in Kids (TRICKs) Ahlers-Schmidt, Carolyn R.
 2012
 30 Supplement 2 p. 5305-5309
5 p.
 artikel
108 Field vaccination of sheep with a larval-specific antigen of the gastrointestinal nematode, Haemonchus contortus, confers significant protection against an experimental challenge infection Piedrafita, D.P.
 2012
 30 Supplement 2 p. 7199-7204
6 p.
 artikel
109 Formulation and evaluation of oral microparticulate ovarian cancer vaccines Tawde, Suprita A.
 2012
 30 Supplement 2 p. 5675-5681
7 p.
 artikel
110 Generation of recombinant bacillus Calmette–Guérin and Mycobacterium smegmatis expressing BfpA and intimin as vaccine vectors against enteropathogenic Escherichia coli Vasconcellos, Halyka Luzorio Franzotti
 2012
 30 Supplement 2 p. 5999-6005
7 p.
 artikel
111 Global Burden of Human Papillomavirus and Related Diseases Forman, David
 2012
 30 Supplement 2 p. F12-F23
nvt p.
 artikel
112 Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity Ott, J.J.
 2012
 30 Supplement 2 p. 2212-2219
8 p.
 artikel
113 Healthcare workers and H1N1 vaccination: Does having a chronic disease make a difference? Toh, Matthias Paul Han Sim
 2012
 30 Supplement 2 p. 1064-1070
7 p.
 artikel
114 Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models Fu, Jie
 2012
 30 Supplement 2 p. 2187-2196
10 p.
 artikel
115 Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003–2010: A retrospective ecological study Beck, Charles R.
 2012
 30 Supplement 2 p. 1965-1971
7 p.
 artikel
116 Heteroclitic peptides enhance human immunodeficiency virus-specific CD8+ T cell responses Gladney, Krista H.
 2012
 30 Supplement 2 p. 6997-7004
8 p.
 artikel
117 Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization Dekker, C.N.T.
 2012
 30 Supplement 2 p. 1379-1387
9 p.
 artikel
118 Hospitalized children with pneumonia in Uruguay: Pre and post introduction of 7 and 13-valent pneumococcal conjugated vaccines into the National Immunization Program Hortal, María
 2012
 30 Supplement 2 p. 4934-4938
5 p.
 artikel
119 Host immune response to A(H1N1)pdm09 vaccination and infection: A one-year prospective study on six cohorts of subjects Liu, Wei
 2012
 30 Supplement 2 p. 4785-4789
5 p.
 artikel
120 Human Papillomavirus, Human Immunodeficiency Virus and Immunosuppression Denny, Lynette A.
 2012
 30 Supplement 2 p. F168-F174
nvt p.
 artikel
121 Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis Poljak, Albina
 2012
 30 Supplement 2 p. 4398-4406
9 p.
 artikel
122 Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy Liu, Kun
 2012
 30 Supplement 2 p. 3034-3041
8 p.
 artikel
123 Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: A proof of concept study in macaques Koopman, Gerrit
 2012
 30 Supplement 2 p. 2523-2534
12 p.
 artikel
124 Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli Wen, Li-Juan
 2012
 30 Supplement 2 p. 3339-3349
11 p.
 artikel
125 Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice Brewoo, Joseph N.
 2012
 30 Supplement 2 p. 1513-1520
8 p.
 artikel
126 Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice Yuan, Wei
 2012
 30 Supplement 2 p. 2490-2497
8 p.
 artikel
127 Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine Porter, Kevin R.
 2012
 30 Supplement 2 p. 336-341
6 p.
 artikel
128 Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial Hirve, Siddhivinayak
 2012
 30 Supplement 2 p. 6456-6460
5 p.
 artikel
129 Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers Klein, Nicola P.
 2012
 30 Supplement 2 p. 3929-3936
8 p.
 artikel
130 Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age Vesikari, Timo
 2012
 30 Supplement 2 p. 3082-3089
8 p.
 artikel
131 Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan Huang, Li-Min
 2012
 30 Supplement 2 p. 2054-2059
6 p.
 artikel
132 Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults Hakim, Hana
 2012
 30 Supplement 2 p. 879-885
7 p.
 artikel
133 Immunogenicity and safety of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, compared with Hiberix™ in Korean infants and children: A randomized trial Kim, Kyung-Hyo
 2012
 30 Supplement 2 p. 1886-1894
9 p.
 artikel
134 Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru Lanata, Claudio F.
 2012
 30 Supplement 2 p. 5935-5941
7 p.
 artikel
135 Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age Van Der Meeren, Olivier
 2012
 30 Supplement 2 p. 2710-2714
5 p.
 artikel
136 Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine Woolpert, Tabitha
 2012
 30 Supplement 2 p. 3090-3096
7 p.
 artikel
137 Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years Njie-Jobe, Jainaba
 2012
 30 Supplement 2 p. 2543-2550
8 p.
 artikel
138 Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales Andrews, Nick J.
 2012
 30 Supplement 2 p. 6802-6808
7 p.
 artikel
139 Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: An overview from Kuwait Mokaddas, Eiman
 2012
 30 Supplement 2 p. G37-G40
nvt p.
 artikel
140 Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme Ingels, Helene
 2012
 30 Supplement 2 p. 3944-3950
7 p.
 artikel
141 Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses Yin, Jiehui Kevin
 2012
 30 Supplement 2 p. 3209-3222
14 p.
 artikel
142 Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007–2010 Costumbrado, John
 2012
 30 Supplement 2 p. 6878-6882
5 p.
 artikel
143 Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults Kikuchi, Tadashi
 2012
 30 Supplement 2 p. 3819-3823
5 p.
 artikel
144 Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge Morello, Christopher S.
 2012
 30 Supplement 2 p. 6541-6550
10 p.
 artikel
145 Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity Fraile, Lorenzo
 2012
 30 Supplement 2 p. 1986-1992
7 p.
 artikel
146 Increasing adolescent immunization by webinar: A brief provider intervention at federally qualified health centers Moss, Jennifer L.
 2012
 30 Supplement 2 p. 4960-4963
4 p.
 artikel
147 Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor Do, Yoonkyung
 2012
 30 Supplement 2 p. 6359-6367
9 p.
 artikel
148 Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo Daenthanasanmak, Anusara
 2012
 30 Supplement 2 p. 5118-5131
14 p.
 artikel
149 Intra-cisternal vaccination induces high-level protection against Neospora caninum infection in mice Debache, Karim
 2012
 30 Supplement 2 p. 4209-4215
7 p.
 artikel
150 Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada De Wals, Philippe
 2012
 30 Supplement 2 p. 6416-6420
5 p.
 artikel
151 In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system Childs, Tawanna S.
 2012
 30 Supplement 2 p. 5942-5948
7 p.
 artikel
152 In vitro derivation of interferon-γ producing, IL-4 and IL-7 responsive memory-like CD4+ T cells Comber, Joseph D.
 2012
 30 Supplement 2 p. 2140-2145
6 p.
 artikel
153 Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses Roth, Bernhard
 2012
 30 Supplement 2 p. 517-522
6 p.
 artikel
154 Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination Li, Xi
 2012
 30 Supplement 2 p. 4581-4584
4 p.
 artikel
155 LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines Zhang, Tong Tong
 2012
 30 Supplement 2 p. 784-793
10 p.
 artikel
156 Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis Shargh, Vahid Heravi
 2012
 30 Supplement 2 p. 3957-3964
8 p.
 artikel
157 Long-term efficacy of 10–12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities Wang, Feng
 2012
 30 Supplement 2 p. 2051-2053
3 p.
 artikel
158 Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh Feller, Andrea J.
 2012
 30 Supplement 2 p. A101-A105
nvt p.
 artikel
159 Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus Heath, David D.
 2012
 30 Supplement 2 p. 7321-7326
6 p.
 artikel
160 Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: Which key messages in light of a new immunization program? Morin, Alyssa
 2012
 30 Supplement 2 p. 5921-5927
7 p.
 artikel
161 Measuring bovine viral diarrhea virus vaccine response: Using a commercially available ELISA as a surrogate for serum neutralization assays Gonda, M.G.
 2012
 30 Supplement 2 p. 6559-6563
5 p.
 artikel
162 Measuring people's knowledge about vaccination: Developing a one-dimensional scale Zingg, Alexandra
 2012
 30 Supplement 2 p. 3771-3777
7 p.
 artikel
163 Meningococcal vaccine development – from glycoconjugates against MenACWY to proteins against MenB – potential for broad protection against meningococcal disease Dull, Peter M.
 2012
 30 Supplement 2 p. B18-B25
nvt p.
 artikel
164 Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine Desai, Kamal
 2012
 30 Supplement 2 p. 2510-2515
6 p.
 artikel
165 Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially Pissani, Franco
 2012
 30 Supplement 2 p. 5519-5526
8 p.
 artikel
166 Nasal and skin delivery of IC31®-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes Wizel, Benjamin
 2012
 30 Supplement 2 p. 4361-4368
8 p.
 artikel
167 No effect of oral polio vaccine administered at birth on mortality and immune response to BCG. A natural experiment Lund, Najaaraq
 2012
 30 Supplement 2 p. 6694-6699
6 p.
 artikel
168 Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice Nanjundappa, Roopa Hebbandi
 2012
 30 Supplement 2 p. 3519-3525
7 p.
 artikel
169 One clinic visit for pre-exposure rabies vaccination (a preliminary one year study) Khawplod, Pakamatz
 2012
 30 Supplement 2 p. 2918-2920
3 p.
 artikel
170 Parental and societal values for the risks and benefits of childhood combination vaccines Gidengil, Courtney
 2012
 30 Supplement 2 p. 3445-3452
8 p.
 artikel
171 Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine Thomas, Brad S.
 2012
 30 Supplement 2 p. 998-1008
11 p.
 artikel
172 Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines Edwards, Morven S.
 2012
 30 Supplement 2 p. 4123-4126
4 p.
 artikel
173 Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations Khatami, Ameneh
 2012
 30 Supplement 2 p. 2831-2838
8 p.
 artikel
174 Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance Nilsson, Lennart
 2012
 30 Supplement 2 p. 3239-3247
9 p.
 artikel
175 Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009 Chen, Wilbur H.
 2012
 30 Supplement 2 p. 4240-4248
9 p.
 artikel
176 Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine Greenberg, Richard N.
 2012
 30 Supplement 2 p. 2245-2249
5 p.
 artikel
177 Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age Dayan, Gustavo H.
 2012
 30 Supplement 2 p. 6656-6664
9 p.
 artikel
178 Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide Zollinger, Wendell D.
 2012
 30 Supplement 2 p. 712-721
10 p.
 artikel
179 Pneumococcal disease in South Australia: Vaccine success but no time for complacency Johnson, David R.
 2012
 30 Supplement 2 p. 2206-2211
6 p.
 artikel
180 Pneumococcal vaccines WHO position paper – 2012 – Recommendations WHO Publication,
 2012
 30 Supplement 2 p. 4717-4718
2 p.
 artikel
181 Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia Benavides, Juan Alberto
 2012
 30 Supplement 2 p. 5886-5892
7 p.
 artikel
182 Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil Andrade, Ana Lucia
 2012
 30 Supplement 2 p. 1901-1909
9 p.
 artikel
183 Potential impact of accelerating the primary dose of rotavirus vaccine in infants Halvorson, Elizabeth E.
 2012
 30 Supplement 2 p. 2738-2741
4 p.
 artikel
184 Potential impact of parental Tdap immunization on infant pertussis hospitalizations Peters, Timothy R.
 2012
 30 Supplement 2 p. 5527-5532
6 p.
 artikel
185 Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children Azzari, Chiara
 2012
 30 Supplement 2 p. 2701-2705
5 p.
 artikel
186 Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B) Shearer, Jeffry D.
 2012
 30 Supplement 2 p. 1917-1926
10 p.
 artikel
187 Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study Učakar, Veronika
 2012
 30 Supplement 2 p. 116-120
5 p.
 artikel
188 Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation Howell-Jones, Rebecca
 2012
 30 Supplement 2 p. 3867-3875
9 p.
 artikel
189 Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka de Silva, Rajiva
 2012
 30 Supplement 2 p. 7561-7565
5 p.
 artikel
190 Probing the protective effects of a conformationally constrained nicotine vaccine Moreno, Amira Y.
 2012
 30 Supplement 2 p. 6665-6670
6 p.
 artikel
191 Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3) Shen, Chun Fang
 2012
 30 Supplement 2 p. 300-306
7 p.
 artikel
192 Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China Liu, Na
 2012
 30 Supplement 2 p. 6940-6945
6 p.
 artikel
193 Prophylactic treatment with Toll-like receptor ligands enhances host immunity to avian influenza virus in chickens St. Paul, Michael
 2012
 30 Supplement 2 p. 4524-4531
8 p.
 artikel
194 Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica Arguedas, Adriano
 2012
 30 Supplement 2 p. 2342-2348
7 p.
 artikel
195 Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2 Joseph, S.K.
 2012
 30 Supplement 2 p. 6477-6482
6 p.
 artikel
196 Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant Amorim, Jaime Henrique
 2012
 30 Supplement 2 p. 837-845
9 p.
 artikel
197 Psychosocial determinants of parents’ intention to vaccinate their newborn child against hepatitis B Harmsen, Irene A.
 2012
 30 Supplement 2 p. 4771-4777
7 p.
 artikel
198 Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years Weycker, Derek
 2012
 30 Supplement 2 p. 5437-5444
8 p.
 artikel
199 Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers Brown, Brandon
 2012
 30 Supplement 2 p. 2309-2314
6 p.
 artikel
200 Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel Ben-Shimol, S.
 2012
 30 Supplement 2 p. 6600-6607
8 p.
 artikel
201 Reduction of HPV infections through vaccination among at-risk urban adolescents Cummings, Teresa
 2012
 30 Supplement 2 p. 5496-5499
4 p.
 artikel
202 Reframing Cervical Cancer Prevention. Expanding the Field Towards Prevention of Human Papillomavirus Infections and Related Diseases Bosch, F. Xavier
 2012
 30 Supplement 2 p. F1-F11
nvt p.
 artikel
203 Relative stability of meningococcal serogroup A and X polysaccharides Berti, F.
 2012
 30 Supplement 2 p. 6409-6415
7 p.
 artikel
204 Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization Thomas-Crusells, Judith
 2012
 30 Supplement 2 p. 6007-6012
6 p.
 artikel
205 Reprint of: Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010 Tali-Maamar, H.
 2012
 30 Supplement 2 p. G25-G31
nvt p.
 artikel
206 Research priorities for global measles and rubella control and eradication Goodson, James L.
 2012
 30 Supplement 2 p. 4709-4716
8 p.
 artikel
207 Research priorities regarding rotavirus vaccine and intussusception: A meeting summary Tate, Jacqueline E.
 2012
 30 Supplement 2 p. A179-A184
nvt p.
 artikel
208 Response of the authors to the letter entitled, “Warning: Differences in the copy number of duplication unit 2 (DU2) within BCG Danish 1331 may influence findings involving genetically-modified BCG Danish strains” by Dr. Douglas S. Kernodle Jain, Ruchi
 2012
 30 Supplement 2 p. 6015-
1 p.
 artikel
209 Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus Fu, Tong-Ming
 2012
 30 Supplement 2 p. 7469-7474
6 p.
 artikel
210 Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: Benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines Lloyd-Johnsen, C.
 2012
 30 Supplement 2 p. A190-A195
nvt p.
 artikel
211 Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders Hoebe, Christian J.P.A.
 2012
 30 Supplement 2 p. 6734-6737
4 p.
 artikel
212 Risk factors of underutilization of childhood immunizations in ultraorthodox Jewish communities in Israel despite high access to health care services Muhsen, Khitam
 2012
 30 Supplement 2 p. 2109-2115
7 p.
 artikel
213 Rotavirus vaccination effectiveness: A case–case study in the EDICS project, Castellón (Spain) Bellido-Blasco, Juan B.
 2012
 30 Supplement 2 p. 7536-7540
5 p.
 artikel
214 Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian population Phua, Kong Boo
 2012
 30 Supplement 2 p. 4552-4557
6 p.
 artikel
215 Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States Krishnarajah, Girishanthy
 2012
 30 Supplement 2 p. 3717-3722
6 p.
 artikel
216 Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel Levine, Hagai
 2012
 30 Supplement 2 p. 7260-7264
5 p.
 artikel
217 Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients Lertdumrongluk, Paungpaga
 2012
 30 Supplement 2 p. 1108-1114
7 p.
 artikel
218 Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates Minervini, Gianmaria
 2012
 30 Supplement 2 p. 1476-1480
5 p.
 artikel
219 Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: Data from two multicentre randomised trials Peeters, Mathieu
 2012
 30 Supplement 2 p. 6483-6491
9 p.
 artikel
220 Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults Seiberling, Michael
 2012
 30 Supplement 2 p. 7455-7460
6 p.
 artikel
221 Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults Halperin, Scott A.
 2012
 30 Supplement 2 p. 5445-5448
4 p.
 artikel
222 Safety and immunogenicity of 2010–2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12–59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study Langley, Joanne M.
 2012
 30 Supplement 2 p. 3389-3394
6 p.
 artikel
223 Safety and immunogenicity of pneumococcal protein vaccine candidates: Monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA–pneumococcal histidine triad protein D vaccine Bologa, Monica
 2012
 30 Supplement 2 p. 7461-7468
8 p.
 artikel
224 Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine Tambyah, Paul A.
 2012
 30 Supplement 2 p. 329-335
7 p.
 artikel
225 Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants Laserson, Kayla F.
 2012
 30 Supplement 2 p. A61-A70
nvt p.
 artikel
226 Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age Vermeulen, Joost N.
 2012
 30 Supplement 2 p. 904-910
7 p.
 artikel
227 School-located influenza immunization programs: Factors important to parents and students Middleman, Amy B.
 2012
 30 Supplement 2 p. 4993-4999
7 p.
 artikel
228 Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa Tapia, Milagritos D.
 2012
 30 Supplement 2 p. A79-A85
nvt p.
 artikel
229 Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria Giwa, F.J.
 2012
 30 Supplement 2 p. 6759-6765
7 p.
 artikel
230 Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection Kim, Sojung
 2012
 30 Supplement 2 p. 2178-2186
9 p.
 artikel
231 SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses Lai, Lilin
 2012
 30 Supplement 2 p. 1737-1745
9 p.
 artikel
232 Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine Kanagavelu, Saravana K.
 2012
 30 Supplement 2 p. 691-702
12 p.
 artikel
233 Statement 2012
 30 Supplement 2 p. v-
1 p.
 artikel
234 Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice Kim, Eun-Hye
 2012
 30 Supplement 2 p. 2008-2019
12 p.
 artikel
235 The association of seasonal influenza vaccination with pandemic influenza H1N1 2009 infection Kelly, Heath
 2012
 30 Supplement 2 p. 2037-2038
2 p.
 artikel
236 The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988–2007) Erhart, Laura M.
 2012
 30 Supplement 2 p. 6103-6110
8 p.
 artikel
237 The development and clinical evaluation of second-generation leishmaniasis vaccines Duthie, Malcolm S.
 2012
 30 Supplement 2 p. 134-141
8 p.
 artikel
238 The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: A randomized controlled trial Dagan, Ron
 2012
 30 Supplement 2 p. 5132-5140
9 p.
 artikel
239 The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27 Bright, Helen
 2012
 30 Supplement 2 p. 7529-7535
7 p.
 artikel
240 The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies Ambrose, Christopher S.
 2012
 30 Supplement 2 p. 886-892
7 p.
 artikel
241 The feasibility of identifying children with primary immunodeficiency disorders: Preparation for the polio post-eradication era in Bangladesh Sazzad, Hossain M.S.
 2012
 30 Supplement 2 p. 5396-5400
5 p.
 artikel
242 The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies Harro, Clayton D.
 2012
 30 Supplement 2 p. 1729-1736
8 p.
 artikel
243 The impact of making vaccines thermostable in Niger's vaccine supply chain Lee, Bruce Y.
 2012
 30 Supplement 2 p. 5637-5643
7 p.
 artikel
244 The recombinant globular head domain of the measles virus hemagglutinin protein as a subunit vaccine against measles Lobanova, Liubov M.
 2012
 30 Supplement 2 p. 3061-3067
7 p.
 artikel
245 The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China Li, Fan
 2012
 30 Supplement 2 p. 7118-7122
5 p.
 artikel
246 The role of nasal IgA in children vaccinated with live attenuated influenza vaccine Ambrose, Christopher S.
 2012
 30 Supplement 2 p. 6794-6801
8 p.
 artikel
247 Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study Carraro, G.
 2012
 30 Supplement 2 p. 1170-1180
11 p.
 artikel
248 Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis Cui, Xia
 2012
 30 Supplement 2 p. 2282-2287
6 p.
 artikel
249 Transcutaneous immunization with Intercell's vaccine delivery system Seid Jr., Robert C.
 2012
 30 Supplement 2 p. 4349-4354
6 p.
 artikel
250 Transmission of a live Eimeria acervulina vaccine strain and response to infection in vaccinated and contact-vaccinated broilers Velkers, Francisca C.
 2012
 30 Supplement 2 p. 322-328
7 p.
 artikel
251 Two decades of hepatitis B vaccination in mentally retarded patients: Effectiveness, antibody persistence and duration of immune memory Braeckman, Tessa
 2012
 30 Supplement 2 p. 4757-4761
5 p.
 artikel
252 Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period De Serres, Gaston
 2012
 30 Supplement 2 p. 4067-4072
6 p.
 artikel
253 Use of the 13-valent conjugate vaccine has the potential to eliminate pilus carrying isolates as causes of invasive pneumococcal disease Aguiar, Sandra I.
 2012
 30 Supplement 2 p. 5487-5490
4 p.
 artikel
254 Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults Potsch, D.V.
 2012
 30 Supplement 2 p. 5973-5977
5 p.
 artikel
255 Vaccination of chickens with Salmonella Pathogenicity Island (SPI) 1 and SPI2 defective mutants of Salmonella enterica serovar Enteritidis Matulova, M.
 2012
 30 Supplement 2 p. 2090-2097
8 p.
 artikel
256 Vaccination with BM86, subolesin and akirin protective antigens for the control of tick infestations in white tailed deer and red deer Carreón, Diana
 2012
 30 Supplement 2 p. 273-279
7 p.
 artikel
257 Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis Zhang, L.
 2012
 30 Supplement 2 p. 2301-2308
8 p.
 artikel
258 Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): Impact on the timeliness of uptake of the primary course of DTPa vaccine Wendy, Bissinger
 2012
 30 Supplement 2 p. 5293-5297
5 p.
 artikel
259 Vaccine and Immunization Surveillance in Ontario (VISION) – Using linked health administrative databases to monitor vaccine safety Wilson, Kumanan
 2012
 30 Supplement 2 p. 6115-6120
6 p.
 artikel
260 Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques Bialuk, Izabela
 2011
 30 Supplement 2 p. 78-94
17 p.
 artikel
261 7-Valent pneumococcal conjugate vaccine and otitis media: Effectiveness of a 2-dose versus 3-dose primary series Stoecker, Charles
 2012
 30 Supplement 2 p. 6256-6262
7 p.
 artikel
262 Waning population immunity to measles in Taiwan Chen, Chih-Jung
 2012
 30 Supplement 2 p. 6721-6727
7 p.
 artikel
263 Warning: Differences in the copy number of duplication unit 2 (DU2) within BCG Danish 1331 may influence findings involving genetically modified BCG Danish strains Kernodle, Douglas S.
 2012
 30 Supplement 2 p. 6013-6014
2 p.
 artikel
264 Workshop on intussusception in African countries – Meeting report Steele, A. Duncan
 2012
 30 Supplement 2 p. A185-A189
nvt p.
 artikel
                             264 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland